Rasi Electrodes (BSE 531233)₹12.73+1.60%Industrial Products
In the Mar 2026 quarter (standalone), Rasi Electrodes reported sales of ₹18.59 Cr, down 8.2% from Mar 2025, and net profit of ₹0.77 Cr, up 13.2% year on year. For the year to Mar 2026, sales were ₹72.13 Cr and net profit ₹3.53 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.82 | 21.58 | 20.78 | 22.79 | 21.29 | 20.66 | 19.36 | 20.26 | 19.44 | 16.81 | 17.29 | 18.59 |
| Expenses | 18.09 | 20.15 | 19.78 | 21.58 | 19.88 | 19.35 | 18.95 | 19.39 | 17.92 | 15.98 | 16.15 | 18.17 |
| Operating Profit | 0.68 | 1.36 | 0.93 | 1.13 | 1.33 | 1.25 | 0.34 | 0.82 | 1.46 | 0.78 | 1.06 | 0.36 |
| OPM % | 3.5% | 6.2% | 4.4% | 4.9% | 6.2% | 6.0% | 1.7% | 4.0% | 7.4% | 4.6% | 6.1% | 1.9% |
| Other Income | 0.28 | 0.05 | 0.29 | 0.45 | 0.08 | 0.30 | 0.26 | 0.27 | 0.38 | 0.48 | 0.16 | 0.79 |
| Interest | 0.08 | 0.02 | 0.07 | 0.04 | 0.05 | 0.03 | 0.03 | 0.04 | 0.02 | 0.00 | 0.00 | 0.04 |
| Depreciation | 0.14 | 0.14 | 0.14 | 0.32 | 0.19 | 0.19 | 0.19 | 0.07 | 0.19 | 0.19 | 0.19 | −0.01 |
| Profit before tax | 0.73 | 1.26 | 1.00 | 1.21 | 1.16 | 1.32 | 0.35 | 0.97 | 1.62 | 1.07 | 1.01 | 1.13 |
| Tax % | 22.2% | 24.8% | 25.2% | 19.1% | 5.2% | 38.2% | 47.1% | 31.2% | 21.7% | 27.3% | 25.9% | 33.0% |
| Net Profit | 0.57 | 0.94 | 0.75 | 0.98 | 1.10 | 0.81 | 0.18 | 0.68 | 1.27 | 0.77 | 0.75 | 0.77 |
| EPS (Rs) | 0.17 | 0.29 | 0.23 | 0.30 | 0.34 | 0.25 | 0.04 | 0.21 | 0.39 | 0.23 | 0.23 | 0.23 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23.14 | 26.87 | 34.31 | 47.55 | 46.02 | 39.49 | 68.49 | 87.64 | 84.00 | 81.55 | 72.13 | 72.13 |
| Expenses | 20.85 | 24.62 | 32.54 | 44.60 | 44.43 | 37.09 | 65.47 | 83.45 | 79.62 | 77.53 | 68.26 | 68.22 |
| Operating Profit | 2.20 | 2.17 | 1.62 | 2.74 | 1.42 | 2.29 | 2.76 | 3.90 | 4.08 | 3.78 | 3.64 | 3.66 |
| OPM % | 9.4% | 8.0% | 4.7% | 5.7% | 3.1% | 5.8% | 4.0% | 4.4% | 4.8% | 4.6% | 5.0% | 5.1% |
| Other Income | 0.70 | 0.58 | 0.61 | 0.55 | 0.72 | 0.86 | 1.18 | 1.43 | 1.06 | 0.82 | 1.80 | 1.81 |
| Interest | 0.39 | 0.50 | 0.72 | 0.69 | 0.47 | 0.38 | 0.45 | 0.47 | 0.19 | 0.15 | 0.06 | 0.06 |
| Depreciation | 0.79 | 0.81 | 0.67 | 0.81 | 0.87 | 0.74 | 0.67 | 0.67 | 0.77 | 0.67 | 0.57 | 0.56 |
| Profit before tax | 1.71 | 1.43 | 0.85 | 1.78 | 0.79 | 2.02 | 2.79 | 4.18 | 4.17 | 3.77 | 4.80 | 4.83 |
| Tax % | 40.5% | 40.1% | −1.2% | 42.3% | 34.6% | 32.8% | 26.6% | 28.0% | 22.8% | 27.4% | 26.5% | — |
| Exceptional items | 0.00 | 0.00 | 0.11 | −0.03 | 0.00 | 0.06 | 0.05 | 0.00 | 0.04 | 0.06 | 0.00 | — |
| Net Profit | 1.02 | 0.86 | 0.86 | 1.03 | 0.52 | 1.37 | 2.06 | 3.02 | 3.21 | 2.75 | 3.53 | 3.56 |
| EPS (Rs) | 0.31 | 0.26 | 0.26 | 0.32 | 0.15 | 0.43 | 0.65 | 0.96 | 1.02 | 0.87 | 1.12 | 1.08 |
| Dividend payout % | 30.8% | 36.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 17.6% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.17 | 6.24 | 6.24 | 6.25 | 6.24 | 6.23 | 6.25 | 6.23 | 6.24 | 6.23 | 6.24 | 6.22 |
| Reserves | 13.64 | 14.50 | 14.85 | 15.68 | 16.65 | 17.11 | 18.32 | 20.28 | 23.31 | 26.46 | 29.17 | 32.77 |
| Borrowings | 3.17 | 5.35 | 4.46 | 5.48 | 5.67 | 2.47 | 5.49 | 9.58 | 3.19 | 1.31 | 1.04 | 0.11 |
| Other Liabilities | 2.37 | 1.76 | 1.93 | 2.16 | 2.48 | 2.85 | 2.73 | 2.30 | 2.03 | 3.43 | 2.83 | 2.24 |
| Total Liabilities | 25.35 | 27.85 | 27.48 | 29.57 | 31.04 | 28.66 | 32.79 | 38.39 | 34.77 | 37.43 | 39.28 | 41.34 |
| Fixed Assets | 6.31 | 6.52 | 6.01 | 5.86 | 6.89 | 7.14 | 6.49 | 6.31 | 6.76 | 6.90 | 6.50 | 5.97 |
| CWIP | 0.12 | 0.00 | 0.03 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.32 |
| Investments | 0.03 | 0.80 | 0.77 | 0.48 | 0.45 | 0.22 | 0.33 | 0.55 | 0.52 | 0.76 | 2.10 | 2.36 |
| Other Assets | 18.89 | 20.53 | 20.67 | 23.23 | 23.70 | 21.27 | 25.97 | 31.53 | 27.49 | 29.77 | 30.68 | 32.69 |
| Inventories | 3.92 | 4.85 | 5.20 | 5.66 | 6.33 | 6.34 | 8.69 | 11.58 | 9.24 | 7.55 | 7.40 | 6.18 |
| Trade receivables | 6.30 | 6.25 | 8.00 | 9.47 | 10.41 | 10.13 | 11.94 | 15.26 | 14.54 | 14.48 | 14.19 | 11.42 |
| Cash & equivalents | 2.66 | 2.96 | 0.72 | 0.97 | 0.59 | 0.50 | 1.10 | 0.50 | 0.32 | 2.07 | 5.14 | 11.00 |
| Total Assets | 25.35 | 27.85 | 27.48 | 29.57 | 31.04 | 28.66 | 32.79 | 38.39 | 34.77 | 37.43 | 39.28 | 41.34 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −3.26 | 0.03 | −0.51 | −0.26 | 1.55 | 4.40 | −2.43 | −3.92 | 7.53 | 4.42 | 4.59 | 6.45 |
| Cash from investing activity | −2.82 | −1.33 | −0.35 | 0.21 | −1.44 | −0.82 | 0.38 | −0.33 | −0.84 | −0.57 | −1.11 | 0.46 |
| Cash from financing activity | 5.99 | 1.64 | −1.39 | 0.30 | −0.50 | −3.67 | 2.64 | 3.64 | −6.85 | −2.07 | −0.41 | −1.00 |
| Net cash flow | −0.10 | 0.32 | −2.25 | 0.24 | −0.39 | −0.10 | 0.61 | −0.62 | −0.19 | 1.77 | 3.08 | 5.88 |
| Capex | 3.24 | 1.81 | 0.31 | 0.52 | 1.83 | 1.11 | 0.00 | 0.51 | 1.11 | 0.85 | 0.33 | 0.05 |
| Free cash flow | −6.58 | −0.99 | −0.84 | −0.73 | −0.29 | 3.21 | −2.41 | −4.41 | 6.37 | 3.53 | 4.22 | 6.03 |
| CFO / OP % | −164.0% | 15.9% | 1.0% | 4.0% | 80.0% | 329.9% | −86.0% | −116.1% | 222.0% | 135.9% | 148.9% | 211.9% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 98 | 99 | 109 | 101 | 80 | 80 | 110 | 81 | 60 | 63 | 63 | 58 |
| Inventory days | 82 | 108 | 103 | 76 | 64 | 68 | 102 | 74 | 47 | 41 | 42 | 40 |
| Days payable | 16 | 4 | 9 | 13 | 13 | 14 | 9 | 1 | 0 | 5 | 2 | 1 |
| Cash conversion cycle | 165 | 203 | 203 | 164 | 131 | 135 | 204 | 154 | 107 | 98 | 103 | 97 |
| Working capital days | 170 | 170 | 191 | 157 | 118 | 126 | 161 | 107 | 95 | 103 | 100 | 113 |
| ROCE % | 9.6% | 8.5% | 7.4% | 5.2% | 9.0% | 4.6% | 8.2% | 9.6% | 13.5% | 12.8% | 10.8% | 12.9% |
For the Mar 2026 quarter, Rasi Electrodes reported sales of ₹18.59 Cr, down 8.2% year on year and net profit of ₹0.77 Cr, up 13.2% year on year. The operating margin was 1.9%.
Rasi Electrodes' sales for the year to Mar 2026 were ₹72.13 Cr; over the last twelve months they were ₹72.13 Cr.
Net profit for the year to Mar 2026 was ₹3.53 Cr, and ₹3.56 Cr over the last twelve months. Earnings per share over the same trailing period were ₹1.08.
Rasi Electrodes reported borrowings of ₹0.11 Cr at Mar 2026, against cash and equivalents of ₹11 Cr.
Cash from operations was ₹6.45 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹6.03 Cr.